234 related articles for article (PubMed ID: 33960252)
1. Nano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation.
Liang Q; Zhou L; Li Y; Liu J; Liu Y
J Drug Target; 2022 Feb; 30(2):119-130. PubMed ID: 33960252
[TBL] [Abstract][Full Text] [Related]
2. The mechanistic immunosuppressive role of the tumour vasculature and potential nanoparticle-mediated therapeutic strategies.
Ileiwat ZE; Tabish TA; Zinovkin DA; Yuzugulen J; Arghiani N; Pranjol MZI
Front Immunol; 2022; 13():976677. PubMed ID: 36045675
[TBL] [Abstract][Full Text] [Related]
3. Vascular normalisation as the stepping stone into tumour microenvironment transformation.
Magnussen AL; Mills IG
Br J Cancer; 2021 Aug; 125(3):324-336. PubMed ID: 33828258
[TBL] [Abstract][Full Text] [Related]
4. Tumour blood vessel normalisation by prolyl hydroxylase inhibitor repaired sensitivity to chemotherapy in a tumour mouse model.
Koyama S; Matsunaga S; Imanishi M; Maekawa Y; Kitano H; Takeuchi H; Tomita S
Sci Rep; 2017 Mar; 7():45621. PubMed ID: 28361934
[TBL] [Abstract][Full Text] [Related]
5. Smart Nanotherapeutic Targeting of Tumor Vasculature.
Li Z; Di C; Li S; Yang X; Nie G
Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
[TBL] [Abstract][Full Text] [Related]
6. In-silico dynamic analysis of cytotoxic drug administration to solid tumours: Effect of binding affinity and vessel permeability.
Vavourakis V; Stylianopoulos T; Wijeratne PA
PLoS Comput Biol; 2018 Oct; 14(10):e1006460. PubMed ID: 30296260
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
Jia M; Zhang D; Zhang C; Li C
J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
[TBL] [Abstract][Full Text] [Related]
8. Nano-targeting vascular remodeling in cancer: Recent developments and future directions.
Giordo R; Wehbe Z; Paliogiannis P; Eid AH; Mangoni AA; Pintus G
Semin Cancer Biol; 2022 Nov; 86(Pt 2):784-804. PubMed ID: 35257860
[TBL] [Abstract][Full Text] [Related]
9. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
Yang S; Gao H
Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
[TBL] [Abstract][Full Text] [Related]
11. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.
Sengupta S; Eavarone D; Capila I; Zhao G; Watson N; Kiziltepe T; Sasisekharan R
Nature; 2005 Jul; 436(7050):568-72. PubMed ID: 16049491
[TBL] [Abstract][Full Text] [Related]
12. Tumour vessel remodelling: new opportunities in cancer treatment.
Ganss R
Vasc Biol; 2020; 2(1):R35-R43. PubMed ID: 32923973
[TBL] [Abstract][Full Text] [Related]
13. [Immune therapy and tumor angiogenesis].
Takakura N
Rinsho Ketsueki; 2020; 61(9):1440-1445. PubMed ID: 33162547
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in tumor microenvironment associated therapeutic strategies and evaluation models.
Haider T; Sandha KK; Soni V; Gupta PN
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111229. PubMed ID: 32806313
[TBL] [Abstract][Full Text] [Related]
15. Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies.
Sung YC; Jin PR; Chu LA; Hsu FF; Wang MR; Chang CC; Chiou SJ; Qiu JT; Gao DY; Lin CC; Chen YS; Hsu YC; Wang J; Wang FN; Yu PL; Chiang AS; Wu AY; Ko JJ; Lai CP; Lu TT; Chen Y
Nat Nanotechnol; 2019 Dec; 14(12):1160-1169. PubMed ID: 31740794
[TBL] [Abstract][Full Text] [Related]
16. Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translation.
Adityan S; Tran M; Bhavsar C; Wu SY
J Control Release; 2020 Nov; 327():512-532. PubMed ID: 32800879
[TBL] [Abstract][Full Text] [Related]
17. Normalization of the tumor microvasculature based on targeting and modulation of the tumor microenvironment.
Li Z; Ning F; Wang C; Yu H; Ma Q; Sun Y
Nanoscale; 2021 Oct; 13(41):17254-17271. PubMed ID: 34651623
[TBL] [Abstract][Full Text] [Related]
18. Modulating tumour vascular normalisation using triptolide-loaded NGR-functionalized liposomes for enhanced cancer radiotherapy.
Xu YY; Chen YH; Jin J; Yuan Y; Li JM; Cai XJ; Zhang RY
J Liposome Res; 2023 Sep; 33(3):251-257. PubMed ID: 36601687
[TBL] [Abstract][Full Text] [Related]
19. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery.
Bouzin C; Feron O
Drug Resist Updat; 2007 Jun; 10(3):109-20. PubMed ID: 17452119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
